Clinical Trial Update: Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors [NA]

View source ↗

Summary

Pilot study of LDE225 (sonidegib) in locally advanced or metastatic basal cell carcinoma previously treated with non-LDE225 Smoothened inhibitors; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• LDE225 (sonidegib) (sonidegib)

Snippet

Sponsor: Anne Chang | Conditions: Basal Cell Carcinoma | NA | Status: COMPLETED | Results posted: 2016-11-02